A Study to Assess Adverse Events and How Single and Multiple Ascending Doses of ABBV-903 Move Through the Body in Healthy Adults

Clinical trial NCT05691699 · COMPLETED

Trial details

NCT number: NCT05691699
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2023-01-03
Primary completion: 2023-10-23
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.